Nivel 5 ATC
L04AC05 - Ustekinumab
24 medicamente în această clasă
Medicamente (20)
| Nume comercial | DCI | Concentrație | Producător |
|---|---|---|---|
| IMULDOSA 130 mg | Ustekinumabum | 130mg | Accord Healthcare B.v. - Tarile de Jos |
| IMULDOSA 45 mg | Ustekinumabum | 45mg/0,5ml | Accord Healthcare B.v. - Tarile de Jos |
| IMULDOSA 90 mg | Ustekinumabum | 90mg/ml | Accord Healthcare B.v. - Tarile de Jos |
| PYZCHIVA 130 mg | Ustekinumabum | 130mg | Samsung Bioepis Nl B.v. - Tarile de Jos |
| PYZCHIVA 45 mg | Ustekinumabum | 45mg/0,5ml | Samsung Bioepis Nl B.v. - Tarile de Jos |
| PYZCHIVA 90 mg | Ustekinumabum | 90mg/ml | Samsung Bioepis Nl B.v. - Tarile de Jos |
| STELARA 130 mg | Ustekinumabum | 130mg | Janssen Biologics B.v. - Olanda |
| Stelara 45 | Ustekinumabum | 45mg/0,5ml | Centocor B.v. - Olanda |
| STELARA 45 mg | Ustekinumabum | 45mg/0,5ml | Janssen Biologics B.v. - Olanda |
| Stelara 90 | Ustekinumabum | 90mg/ml | Centocor B.v. - Olanda |
| STELARA 90 mg | Ustekinumabum | 90mg/ml | Janssen Biologics B.v. - Olanda |
| STEQEYMA 130 mg | Ustekinumabum | 130mg | Nuvisan France Sarl - Franta |
| STEQEYMA 45 mg | Ustekinumabum | 45mg/0,5ml | Nuvisan France Sarl - Franta |
| STEQEYMA 90 mg | Ustekinumabum | 90mg/ml | Nuvisan France Sarl - Franta |
| USYMRO 130 mg | Ustekinumabum | 130mg | Cilatus Manufacturing Services Limited - Irlanda |
| USYMRO 45 mg | Ustekinumabum | 45mg/0,5ml | Cilatus Manufacturing Services Limited - Irlanda |
| USYMRO 90 mg/ml | Ustekinumabum | 90mg/ml | Cilatus Manufacturing Services Limited - Irlanda |
| UZPRUVO 130 mg | Ustekinumabum | 130mg | Alvotech Hf - Islanda |
| UZPRUVO 45 mg | Ustekinumabum | 45mg/0,5ml | Alvotech Hf - Islanda |
| UZPRUVO 90 mg | Ustekinumabum | 90mg/ml | Alvotech Hf - Islanda |
Substanțe active în L04AC05
Clase înrudite
L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab L04AC19 Satralizumab L04AC21 (l04ac21) L04AC22 (l04ac22) L04AC24 (l04ac24)